FDA advisers give thumbs up to MannKind's inhaled insulin drug for diabetics The U.S. FDA panel of advisers okays insulin that can be inhaled rather than injected. This would be the third time that MannKind, its manufacturer, has sought approval from the FDA for its new drug called Afrezza. by Maryanne Moll